Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA by Investing.com
Hong Kong, January 26, 2025 /prnewswire/- Akeso, Inc. (9926.hk)("AkesoThe Company (or the…
CDC confirms first severe case of bird flu in the U.S.
US Dozens of cases of human bird influenza infection have been confirmed…
Surprising discovery reveals that severe coronavirus infection can shrink tumors: ScienceAlert
Attractive new work studyPublished in clinical research journalhas revealed an unexpected potential…
See on map: Severe Cyclone Dana hits India, 1 million people evacuated
Sign up for our breaking news emails to get real-time breaking news…
Severe solar storm expected to hit Earth this week: ScienceAlert
A giant plasma ball ejected from the sun and its accompanying magnetic…
Shocking video shows two killed in severe flooding in Connecticut
Playing video content AP At least a foot of water flooded Connecticut…
Severe Storm Maria batters Japan, dumping heavy rains, cancelling flights and forcing thousands to seek shelter
Sign up to Independent Climate emails to receive the latest advice on…
